Composition Comprising The Extracts of Lindera Obtusiloba as Effective Ingredient for Prevention And Treatment of Thrombosis
    2.
    发明公开
    Composition Comprising The Extracts of Lindera Obtusiloba as Effective Ingredient for Prevention And Treatment of Thrombosis 有权
    组合物与三桠乌药的提取物作为血栓形成的预防和治疗中的活性成分

    公开(公告)号:EP2687263A1

    公开(公告)日:2014-01-22

    申请号:EP13188806.7

    申请日:2010-11-19

    IPC分类号: A61P7/02 A23L1/30 A61K36/54

    摘要: Provided is a composition for improving blood circulation, comprising an extract of Lindera obtusiloba as an active ingredient, and more specifically, to a pharmaceutical composition and a health functional food for preventing and treating thrombolic disorders by improving blood circulation, comprising an extract of Lindera obtusiloba as an active ingredient. The extract of Lindera obtusiloba of the present invention and a crude purified product thereof can be obtained through extraction using various solvents such as water, ethanol, methanol, butanol, etc. Since the extract and the crude purified product have not only excellent inhibitory effect on platelet aggregation induced by various aggregation inductions in vitro, but also excellent inhibitory effect on rapid thrombus formation in vivo, they can be useful for preventing and treating diseases caused by blood circulation disorders such as thromboembolism, etc.

    摘要翻译: 提供了一种用于改善血液循环,三桠乌药的提取物包含作为活性成分的,并且更具体地说,涉及一种药物组合物,以及预防和改善血液循环,治疗thrombolic病症的健康功能食品,其包括三桠乌药提取物的组合物 作为活性成分。 例如水,乙醇,甲醇,丁醇,等。由于该提取物,将粗纯化的产物对不仅具有优良的抑制效果:本发明的三桠乌药和粗精制物的提取物可以通过使用各种溶剂萃取而获得 通过体外,即但在体内快速血栓形成具有优异的抑制效果的各种聚合导入诱导的血小板聚集,它们可用于预防和治疗由血液循环障碍引起的疾病有用:如血栓栓塞,等

    Disazo dyes and dye compositions for shading white paper
    5.
    发明授权
    Disazo dyes and dye compositions for shading white paper 有权
    二重氮染料和染料组合物用于遮蔽白纸

    公开(公告)号:EP1899418B1

    公开(公告)日:2012-04-18

    申请号:EP06763877.5

    申请日:2006-06-26

    申请人: BASF SE

    IPC分类号: C09B31/08 D21H21/30 D21H21/28

    CPC分类号: D21H21/28 C09B31/08

    摘要: The invention relates to novel dyes of the formula (1) in which D represents a phenyl or naphthalene residue which is substituted by one or two sulphonic Acid or carboxylic acid groups and, optionally, by one or two groups selected from C1-C4alkyl, hydroxyl and nitro, each R1 and R2, independently, represent hydrogen or, a C1-C4alkyl group, R'1 represents hydrogen, hydroxyl, C1-C4alkyl or C1-C4hydroxyalkyl, R3 represents hydrogen, C1-C4alkyl or phenyl, which is unsubstituted or substituted by one or two groups selected from C1-C4alkyl, C1-C4alkoxy, halogen, hydroxyl, -NH2, nitro, -SO3M and -CO2M and M represents hydrogen, an alkaline or alkaline earth metal, ammonium or ammonium that is mono-, di-, tri- or tetrasubstituted by C1-C4alkyl or C2-C4hydroxyalkyl or a polyglycolammonium cation and also known dyes of formula (5), in which D' represents a phenyl or naphthalene residue which is substituted by one or two sulphonic acid or carboxylic acid groups and, optionally, by one or two groups selected from C1-C4alkyl and C1-C4alkoxy and R3 and M are as defined above, and their mixtures suitable for shading white paper, a process for shading, a process for the preparation of the novel dyes and white paper which has been treated with such shading components.

    Coating fluid for forming undercoat layer and electrographic photoreceptor having undercoat layer formed by applying said coating fluid
    7.
    发明公开
    Coating fluid for forming undercoat layer and electrographic photoreceptor having undercoat layer formed by applying said coating fluid 有权
    涂布液用于形成底涂层和感光体电图与通过将形成所述涂层液体底涂层

    公开(公告)号:EP2196860A3

    公开(公告)日:2011-06-08

    申请号:EP10003600.3

    申请日:2005-10-03

    发明人: Fuchigami, Hiroe

    IPC分类号: G03G5/14 G03G5/00

    CPC分类号: G03G5/144 G03G5/142

    摘要: Electrophotographic photoreceptor capable of forming a high quality image in various environments, with which image defects such as black spots or color spots hardly occur, an image forming apparatus using such a photoreceptor, and an electrophotographic cartridge using such a photoreceptor.
    The electrophotographic photoreceptor comprises an electroconductive substrate, an undercoat layer containing a binder resin and metal oxide particles having a refractive index of at least 2.0 formed on the electroconductive substrate, and a photosensitive layer formed on the undercoat layer, characterized by satisfying the following (1) or (2):
    (1) the ratio of the specular reflection of the undercoat layer calculated as a thickness of 2 µm to a light having a wavelength of 480 nm, to the specular reflection of the electroconductive substrate to a light having a wavelength of 480 nm, is at least 50%, or
    (2) the ratio of the specular reflection of the undercoat layer calculated as a thickness of 2 um to a light having a wavelength of 400 nm, to the specular reflection of the electroconductive substrate to a light having a wavelength of 400 nm, is at least 50%.

    A combination comprising a magnet and a magnetic cell
    9.
    发明公开
    A combination comprising a magnet and a magnetic cell 审中-公开
    组合aus einem磁铁和磁铁Magnetzelle

    公开(公告)号:EP2182053A1

    公开(公告)日:2010-05-05

    申请号:EP09015815.5

    申请日:2004-06-25

    发明人: Ochi, Mitsuo

    IPC分类号: C12N5/00

    摘要: The present invention relates to a combination comprising:
    a magnet; and
    a magnetic cell comprising:
    a cell having integrin on a surface thereof; and

    a magnetic particle comprising a peptide having an adhesive activity for integrin and
    a magnetic material, wherein an amount of coating of the peptide onto the magnetic particles is from 3 ng to 6.6 µg based on 1 mg of the magnetic particle.

    摘要翻译: 本发明涉及一种组合,包括:磁体; 以及磁性电池,包括:在其表面上具有整联蛋白的细胞; 以及包含对整联蛋白和磁性材料具有粘合活性的肽的磁性粒子,其中,所述肽在磁性粒子上的涂布量相对于1mg磁性粒子为3ng〜6.6μg。

    Novel peptide and pharmaceutical use of the same
    10.
    发明公开
    Novel peptide and pharmaceutical use of the same 有权
    Kombination von Peptiden und pharmazeutische Verwendung davon

    公开(公告)号:EP2172474A1

    公开(公告)日:2010-04-07

    申请号:EP10000425.8

    申请日:2002-12-03

    摘要: The present invention relates to an agent for treating a corneal disorder, the agent comprising the following components:
    (1) a peptide consisting of the amino acid sequence represented by Ser-Ser-Ser-Arg-Arg, Gly-Ser-Ser-Ser-Arg, Gly-Ser-Ser-Ser-Arg-Arg, Ala-Ser-Ser-Ser-Arg-Arg-Ala-Pro, Gly-Ser-Ser-Ser-Arg-Ala-Ala-Pro, Gly-Ser-Ser-Ser-Arg-Arg-Ala-Pro or Gly-Ser-Ser-Ser-Arg-Ala-Ala-Ala-Pro or pharmaceutically acceptable salts thereof and,
    (2) a peptide consisting of the amino acid sequence represented by Phe-Gly-Leu-Met-NH2 or substance P or pharmaceutically acceptable salts thereof.

    摘要翻译: 本发明涉及用于治疗角膜疾病的药剂,该试剂包含以下成分:(1)由Ser-Ser-Ser-Arg-Arg,Gly-Ser-Ser-Ser -Arg,Gly-Ser-Ser-Ser-Arg-Arg,Ala-Ser-Ser-Ser-Arg-Arg-Ala-Pro,Gly-Ser-Ser-Ser-Arg-Ala-Ala-Pro,Gly-Ser -Ser-Ser-Arg-Arg-Ala-Pro或Gly-Ser-Ser-Ser-Arg-Ala-Ala-Ala-Pro或其药学上可接受的盐,和(2) Phe-Gly-Leu-Met-NH 2或物质P或其药学上可接受的盐。